| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.56T | 1.45T | 1.33T | 1.24T | 1.06T |
| Gross Profit | 355.47B | 309.94B | 280.99B | 259.20B | 224.00B |
| EBITDA | 101.98B | 90.96B | 83.40B | 86.70B | 67.15B |
| Net Income | 42.69B | 35.87B | 29.97B | 22.76B | 31.91B |
Balance Sheet | |||||
| Total Assets | 620.53B | 560.77B | 535.58B | 503.15B | 425.11B |
| Cash, Cash Equivalents and Short-Term Investments | 85.02B | 82.82B | 108.37B | 101.23B | 107.55B |
| Total Debt | 84.11B | 77.28B | 68.99B | 78.11B | 55.63B |
| Total Liabilities | 381.74B | 354.38B | 327.26B | 319.62B | 220.74B |
| Stockholders Equity | 219.50B | 189.63B | 192.35B | 169.67B | 183.05B |
Cash Flow | |||||
| Free Cash Flow | 73.59B | 63.72B | 74.47B | 65.72B | 48.09B |
| Operating Cash Flow | 77.44B | 68.85B | 77.75B | 68.98B | 50.69B |
| Investing Cash Flow | -34.32B | -29.77B | -19.00B | -22.79B | -7.06B |
| Financing Cash Flow | -44.82B | -63.88B | -53.80B | -41.78B | -21.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥14.72T | 30.04 | 27.29% | 0.27% | 3.93% | 29.13% | |
75 Outperform | ¥143.47B | 14.92 | ― | 2.38% | 15.54% | 40.98% | |
74 Outperform | ¥231.28B | 15.52 | 28.98% | 5.57% | 3.47% | 18.14% | |
69 Neutral | ¥522.63B | 12.15 | 19.18% | 3.59% | 7.21% | 20.34% | |
69 Neutral | ¥107.61B | 13.95 | ― | 7.51% | -14.32% | -17.67% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
42 Neutral | ¥56.32B | -12.49 | -6.02% | 0.77% | -3.21% | -104.97% |